ArticleMolecular and cellular biology2024

A Genome Wide CRISPR Screen Reveals That HOXA9 Promotes Enzalutamide Resistance in Prostate Cancer.

Michael V Roes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.